We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Single Amino Acid Substitution Enlarges Heart

By Biotechdaily staff writers
Posted on 17 Mar 2003
Researchers have found that a mutation in the gene that codes for phospholamban, a transmembrane phosphoprotein, causes dilated cardiomyopathy, a disorder that results in the heart becoming enlarged to the point where it can no longer pump blood efficiently. More...
This finding was published in the February 28, 2003, issue of Science.

Armed with the knowledge that a single amino acid substitution in phospholamban typified a group of patients with inherited dilated cardiomyopathy, researchers from Harvard Medical School (Boston, MA, USA) genetically engineered a line of mice that expressed the same mutation.

"Substituting only one amino acid in phospholamban produced profound changes in cardiac function, causing a premature death of the mice with evidence of heart failure that recapitulates what we saw in our human families,” said senior author Dr. Christine E. Seidman, a professor at Harvard Medical School.

The heart muscle is signaled to contract and relax by a mechanism in which calcium is released from the sarcoplasmic reticulum into the myocytes and then rapidly pumped back into the sarcoplasmic reticulum. Phospholamban is a key regulatory molecule in the calcium reuptake pump.

"We believe these findings point to defects in this recycling of calcium that do not allow the myocyte to fully relax. These can lead to profoundly devastating consequences,” explained Dr. Seidman. "Before our work, it was thought that calcium dysregulation might be involved in dilated cardiomyopathy, but it was uncertain whether this was contributing to myocyte dysfunction (i.e., an inciting event) or a secondary consequence, and that is a big difference.”


New
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Prefilled Tubes
Prefilled 5.0ml Tubes
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.